Pablo
Vidal Cortes
Publications (35) Pablo Vidal Cortes publications
2024
-
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients
International Journal of Infectious Diseases, Vol. 144
2023
-
A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study
Respiratory Research, Vol. 24, Núm. 1
-
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients
Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33
-
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 238-242
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
-
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis
The European respiratory journal, Vol. 61, Núm. 3
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
-
Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
The Journal of infection, Vol. 86, Núm. 3, pp. 256-308
-
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 20
2022
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
-
Enhancing sepsis management through machine learning techniques: A review
Medicina Intensiva, Vol. 46, Núm. 3, pp. 140-156
-
Impact of one year of pandemic on Spanish Intensive Care Units
Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 392-400
-
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis
Intensive Care Medicine, Vol. 48, Núm. 11, pp. 1593-1606
-
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units
Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89
-
Resuscitation strategy for patients with sepsis and septic shock
Medicina Intensiva, Vol. 46, pp. 60-71
-
Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections
Medicina Intensiva, Vol. 46, Núm. 9, pp. 508-520
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study
Annals of Intensive Care, Vol. 11, Núm. 1